Clonazepam has extensive been recognized as among the best-proven therapies for prolonged-time period neurological and psychiatric care as a result of its precision mechanism of motion, prolonged fifty percent-lifetime and established medical reliability. Its ability to selectively bind to GABA-A receptors and stabilize hyperactive neural pathways